Discover budget-friendly apps that handle symbolic math, image edits, document compatibility, and video editing so you can ...

OpenAI has launched Computer History, an opt-in feature in the ChatGPT desktop app on macOS that records what a user does ...

Spread the love“`html If you’ve ever tried to manage a group project, plan a family event, or just keep track of ideas with a colleague, you know the pain of scattered notes. Emails fly back and forth ...

OpenAI has acquired NextSlide, a startup that built software for turning raw material into finished presentations, with the ...

Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...

Google may have just released a game-changer feature for Gemini users who like to export their AI sessions to documents. Instead of having to copy and paste, reformat, or deal with external apps not ...

You can now ask the Gemini app to directly generate “downloadable and ready-to-share files.” Google wants you to “quickly move from a brainstorm to a complete ...

Gemini can now generate and package downloadable files directly in chat. The chatbot is capable of generating files in a variety of formats, including HTML, PDF, XML, and more. It appears that ...

Samsung is shutting down Samsung Notes sync with Microsoft OneNote. The “Sync to Microsoft OneNote” option stops working after July 2026, with no clear reason given. If you use Samsung Notes to stay ...

Years back, OneNote 2007 stopped working correctly for me. I managed to transition the notebook to the Windows App that you can use on desktop pc. All worked ok'ish. I managed to put the notebook in a ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...